Aims and Scope
Journal of Lung Cancer Epidemiology (JLCE) is a premier, open-access, peer-reviewed international journal dedicated to advancing the scientific understanding of lung cancer epidemiology. JLCE serves as a platform for cutting-edge research that explores the etiology, prevention strategies, and clinical implications of lung cancer, with a strong emphasis on public health impact and evidence-based medicine.
JLCE covers all aspects of lung cancer epidemiology, including but not limited to:
- Molecular & Genetic Epidemiology: Investigating genetic susceptibility, biomarkers, and personalized risk assessments.
- Risk Factor Analysis: Examining the role of smoking, air pollution, occupational exposure, and other environmental carcinogens.
- Cancer Prevention & Public Health Strategies: Evaluating tobacco control policies, early detection programs, and global prevention initiatives.
- Epidemiologic Trends & Surveillance: Tracking incidence, prevalence, and survival trends across different populations.
- Clinical Implications of Epidemiology: Exploring how epidemiologic data informs early diagnosis, treatment decisions, and patient outcomes.
- Biomarker Research & Genetic Testing: Investigating novel diagnostic and prognostic markers for lung cancer.
- Health Disparities & Global Perspectives: Addressing socioeconomic and geographic disparities in lung cancer burden and access to care.
- Occupational & Environmental Carcinogens: Studying exposure-related lung cancer risks in industrial and environmental settings.
- Artificial Intelligence & Big Data in Epidemiology: Leveraging machine learning and computational approaches for lung cancer risk prediction and analysis.
The editorial team encourages manuscripts from all relevant disciplines, including but not limited to
- Public health
- Symptoms of Lung Cancer
- Oxidative phosphorylation
- Small cell lung cancer
- Molecular biology
- Biostatistics
- Non-Small Cell Lung Cancer
- Lung Cancer Staging
- Squamous cell cancer
- e-cigarettes
- lung health
- Allied medical sciences
- Incidence and mortality
- Squamous cell carcinoma
- Oncology
- Lung cancer
- Radiotherapy and Chemotherapy
- Lung cancer incidence
- Lung cancer mortality
- Lung cancer survival
- Lung cancer screening
- Lymphocytes
- Lung cancer risk factors
- Smoking and lung cancer
- Secondhand smoke and lung cancer
- Occupational exposure and lung cancer
- Environmental exposure and lung cancer
- Genetics and lung cancer
- Biomarkers for lung cancer
- Early detection of lung cancer
- Lung cancer staging
- Lung cancer treatment
- Surgery for lung cancer
- Adenocarcinoma
- Radiation therapy for lung cancer
- Chemotherapy for lung cancer
- Immunotherapy for lung cancer
- Targeted therapy for lung cancer
- Mesothelioma
- Palliative care for lung cancer
- Lung cancer clinical trials
- Lung cancer prevention
- Lung cancer awareness
- Lung cancer education
- Lung cancer disparities
- Lung cancer epidemiology
- Lung cancer incidence trends
- Lung cancer mortality trends
- Lung cancer survival rates
- Lung cancer screening guidelines
- Lung cancer screening eligibility
- Lung cancer screening adherence
- Lung cancer screening controversies
- Lung cancer risk assessment
- Lung cancer risk reduction
- Lung cancer risk communication
- Lung cancer risk perception
- Lung cancer prevention policies
- Lung cancer treatment decision-making
- Lung cancer treatment outcomes
- Lung cancer treatment complications
- Lung cancer survivorship
